Hydromer, Inc.

HYDI

US4490011065

Specialty Chemicals

Market Closed - Nyse Other stock markets 10:11:52 08/05/2024 pm IST			5-day change	1st Jan Change
0.54 ^USD	+2.82%		+2.82%	+191.89%

16/01	Hydromer, Inc. Announces Sales Results for the Fiscal Year Ended December 31, 2023	CI
16/01	Hydromer, Inc. Revises Fiscal Year from June 30 to December 31	CI

Hydromer, Inc. and N8 Medical Partner to Bring Life-Saving Coated ET Tubes for COVID-19 Patients

April 25, 2020 at 02:13 am IST

Hydromer, Inc. announced that it will be the exclusive coating supplier and manufacturing partner for N8 Medical’s CeraShield™ Endotracheal Tube. Health Canada has granted emergency use access marketing approval for the CeraShield™ Endotracheal Tube for all Canadian mechanically-ventilated COVID-19 patients.

Latest news about Hydromer, Inc.

Hydromer, Inc. Announces Sales Results for the Fiscal Year Ended December 31, 2023	17/01	CI
Hydromer, Inc. Revises Fiscal Year from June 30 to December 31	17/01	CI
Hydromer, Inc. Announces the Relaunch of its Legendary SeaSlide?? Hydrophilic Watercraft Coating	17/01	CI
Hydromer, Inc. Announces Board Changes	08/23/08	CI
Hydromer, Inc Appoints Michael E. Torti as Chief Executive Officer	26/23/26	CI
Hydromer, Inc. Removes Peter Von Dyck as CEO	07/23/07	CI
Hydromer, Inc. Appoints Cam Cruickshank as Board of Directors	11/23/11	CI
Hydromer, Inc. Appoints Cortney Wells as Director of Finance	09/22/09	CI
Hydromer, Inc. Announces That New Facility in North Carolina Is Fully Operational with Extensive New Capabilities	23/21/23	CI
Hydromer Inc. Announces the Addition of A New Global Business Development Manager to Propel Growth	29/21/29	CI
Hydromer Selected as Key Coatings Provider for Avinger’s Image-Guided PAD Therapeutic Devices	20/21/20	CI
Hydromer Inc Signs Agreement to Sell Their Hand and Surface Sanitizer Lines, Hydromer First Responder, HydroProtect and EscenciaProtect on the Stockd e-Commerce Marketplace	04/20/04	CI
Hydromer as the Exclusive Coatings Partner for N8 Announces the CeraShield Coating Has Demonstrated the Ability to Inhibit and Reduce the Growth of Covid-19 Virus on Tube Surfaces	18/20/18	CI
Hydromer Accelerates Its First Responder Sanitizer Production to Meet Growing Demand	01/20/01	CI
Hydromer, Inc. and N8 Medical Partner to Bring Life-Saving Coated ET Tubes for COVID-19 Patients	25/20/25	CI
N8 Medical, LLC Partners with Hydromer Inc. and Biosearch Medical Products, Inc for Material Supply and Production of the CeraShield	24/20/24	CI
Hydromer Enters into New Commercial Relationship Agreements with Multiple Clients to Kick-Off the New Year 2020	14/20/14	CI
Hydromer Inc. Announces its Partnership With EuroDev to Expand on Demand for its Specialty Coatings Products in Europe	07/19/07	CI
Hydromer Inc. Announces the Launch of Its Next Generation Website to Provide Clients with A Better User Experience	12/19/12	CI
Hydromer, Inc. Announces Board Appointments	04/19/04	CI
Hydromer Inc. Announces Advancement of Manufacturing Capabilities with Relocation to North Carolina	24/19/24	CI
Hydromer, Inc. Announces Management Changes	30/19/30	CI
Hydromer, Inc. Announces Dividend, Payable on October 8, 2018	19/18/19	CI
Hydromer, Inc Announces Executive Changes	14/18/14	CI
Huvepharma AD acquired T-HEXX animal healthcare business of Hydromer, Inc. for $6.5 million.	28/18/28	CI

Chart Hydromer, Inc.

Duration

Period

More charts

Company Profile

Hydromer, Inc. is a provider of hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices. The Company is engaged in providing business-to- business (B2B) surface modification and coating solutions provider. The Company offers polymer research and development, and manufacturing services capabilities for a variety of applications. Its customers are located across North and South America, Europe, the Middle East, and Asia-Pacific. Its segments include Medical and Industrial. Medical segment provides medical coatings support to specialized FDA approved medical devices and medical coatings that reduce insertion and withdrawal friction and potential trauma and enhance the performance of medical devices used in anatomies of the human body. The Industrial segment provides customized anti-fog, anti-frost, and condensation-control coating solutions for a variety of applications on many substrates including polycarbonate, glass, metal, and polyurethane.

Sector

Specialty Chemicals

More about the company

Sector Other Specialty Chemicals

	1st Jan change	Capi.
HYDROMER, INC.	+191.89%	2.98M
ECOLAB INC.	+16.84%	66.18B
SIKA AG	+0.88%	49.24B
GIVAUDAN SA	+16.50%	41.72B
FUJIFILM HOLDINGS CORPORATION	+22.44%	26.16B
EMS-CHEMIE HOLDING AG	+11.75%	19.75B
CELANESE CORPORATION	+3.13%	17.5B
POSCO FUTURE M CO., LTD.	-23.12%	15.63B
ALBEMARLE CORPORATION	-8.98%	15.46B
SYMRISE AG	+2.57%	15.43B

Other Specialty Chemicals

Hydromer, Inc.

Equities

HYDI

US4490011065

Specialty Chemicals

Hydromer, Inc. and N8 Medical Partner to Bring Life-Saving Coated ET Tubes for COVID-19 Patients

Latest news about Hydromer, Inc.

Chart Hydromer, Inc.

Company Profile

Sector Other Specialty Chemicals